共 35 条
Structural Characterization, Antioxidant, and Antiviral Activity of Sulfated Polysaccharide (Fucoidan) from Sargassum asperifolium (Turner) J. Agardh
被引:0
作者:
Ageeli, Abeer A.
[1
]
Mohamed, Sahera Fathalla
[1
]
Fenice, Massimiliano
Faustino, M. Amparo F.
机构:
[1] Jazan Univ, Coll Sci, Chem Dept, POB 114, Jazan 45142, Saudi Arabia
来源:
CHEMISTRY-SWITZERLAND
|
2023年
/
5卷
/
04期
关键词:
brown algae;
fucoidan;
Sargassum asperifolium;
antioxidant;
antiviral activity;
SIMPLEX-VIRUS TYPE-1;
BROWN;
ANTICOAGULANT;
INHIBITION;
MECHANISMS;
PROTECTION;
CARCINOMA;
PROTEIN;
GROWTH;
CELLS;
D O I:
10.3390/chemistry5040176
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
Brown algae possess a diverse array of acidic polysaccharides, including fucoidan. The present research intends to investigate the extraction and characterization of algal polysaccharides to explore their antiviral activity. A light brown sulfated polysaccharide was extracted (with a yield of 18% of dry weight) from Sargassum asperifolium algal powder. The results of fractionation of sulfated polysaccharide revealed the occurrence of two primary fractions: low-sulfated polysaccharides (SPF1) and high-sulfated polysaccharides (SPF2). The bioassays conducted on SPF2 demonstrated a greater level of antioxidant activity compared to SPF1, with respective IC50 values of 17 +/- 1.3 mu g/mL and 31 +/- 1.1 mu g/mL after a duration of 120 min. The cytotoxicity of SPF2 on Vero cells was determined, and the calculated half-maximal cytotoxic concentration (CC50) was found to be 178 +/- 1.05 mu g/mL. Based on these results, an antiviral activity assay was conducted on SPF2. The results demonstrated that SPF2 had greater efficacy against Hepatitis A Virus (HAV) compared to Herpes Simplex Virus Type 1 (HSV-1), with corresponding half-maximal inhibitory concentrations (IC50) of 48 +/- 1.8 mu g/mL and 123 +/- 2.6 mu g/mL, respectively. The active SPF2 was characterized by FT-IR, H-1, and C-13 NMR spectroscopy. The extracted fucoidan can be used as a natural therapeutic agent in combating various viral infections.
引用
收藏
页码:2756 / 2771
页数:16
相关论文